다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NYSE
Panacea Acquisition Corp (NUVB)
Panacea Acquisition Corp (NUVB) 뉴스

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:NUVB

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NUVB	Panacea Acquisition Corp
2024/05/15	05:28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NUVB	Panacea Acquisition Corp
2024/05/15	05:20	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2024/05/15	05:05	Business Wire	Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update	NYSE:NUVB	Panacea Acquisition Corp
2024/04/24	23:01	Business Wire	Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NYSE:NUVB	Panacea Acquisition Corp
2024/04/11	05:01	Business Wire	Nuvation Bio Completes Acquisition of AnHeart Therapeutics	NYSE:NUVB	Panacea Acquisition Corp
2024/03/28	21:00	Business Wire	Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer	NYSE:NUVB	Panacea Acquisition Corp
2024/03/25	20:00	Business Wire	Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction	NYSE:NUVB	Panacea Acquisition Corp
2024/03/15	05:05	Business Wire	Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors	NYSE:NUVB	Panacea Acquisition Corp
2024/03/05	07:30	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:NUVB	Panacea Acquisition Corp
2024/03/05	07:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2024/03/05	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2024/03/05	06:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2024/03/01	07:06	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:NUVB	Panacea Acquisition Corp
2024/03/01	06:48	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2024/03/01	06:01	Business Wire	Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NYSE:NUVB	Panacea Acquisition Corp
2024/01/11	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2024/01/11	06:21	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2024/01/09	06:58	Dow Jones News	Nuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor Treatment	NYSE:NUVB	Panacea Acquisition Corp
2024/01/09	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2024/01/09	06:10	Business Wire	Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors	NYSE:NUVB	Panacea Acquisition Corp
2024/01/09	06:05	Business Wire	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors	NYSE:NUVB	Panacea Acquisition Corp
2023/12/15	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2023/11/28	06:09	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NUVB	Panacea Acquisition Corp
2023/11/28	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2023/11/14	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2023/11/14	06:05	Business Wire	Nuvation Bio Announces Departure of Chief Financial Officer	NYSE:NUVB	Panacea Acquisition Corp
2023/11/03	05:23	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NUVB	Panacea Acquisition Corp
2023/11/03	05:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NUVB	Panacea Acquisition Corp
2023/11/03	05:10	Business Wire	Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update	NYSE:NUVB	Panacea Acquisition Corp

검색 관련기사 보기:NYSE:NUVB

1 2 3 4 5 6 다음 >>

Granite 3s Nflx

Pono Capital Two

Shelton Nasdaq 100 Index...

WT WTI Crude Oil

DMM: Governance

Strategic International ...

Global Technologies (CE)

Interest Rate Hedge Port...

Metals Australia

National Housing Finance...

Polo Credito Imobiliario...

USDP Stablecoin

ProShares Ultra Consumer...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관